RT Journal Article
SR Electronic
T1 Predicting COVID19 Critical Care Beds - The London North-West University Healthcare Trust Experience
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.20.20235226
DO 10.1101/2020.11.20.20235226
A1 Naude, J.A
A1 Taniparthi, M.
A1 Adams, K.
A1 Biggin-Lamming, J.
A1 Elias, R.
A1 Milner, P.
A1 Mohammed, I.
A1 Towers, M.
A1 Kuper, M.
YR 2020
UL http://medrxiv.org/content/early/2020/11/23/2020.11.20.20235226.abstract
AB Our trust has an urgent need to make short-term (3-4 days in advance) informed operational decisions which take into account best-practice treatment regimens and known clinical features of COVID19 inpatients.We believe that any model which is relied upon for operational decision making should have clinically identifiable parameters. Our model’s parameters take into account the conversion rates from acute wards into wards equipped with Non-Invasive Ventilation (NIV) and Mechanical Ventilation (MV), the typical time that these conversions take place and, the historical non-COVID usage of NIV and MV beds.We have observed that this clinical performance is mathematically identical to a series of linear delays on the time varying inpatient level. High frequency inpatient data, sampled ∼4 hourly, has allowed our hospital trust to predict total critical care usage up to 4 days in advance without making any assumptions on upcoming inpatients. It is based entirely upon current bed occupancy levels and measured clinical pathways.Through back-testing over the recent 4 months, the bounds of this model include 93.8% of all 4 day inpatient sequences. The average next-day error is 0.8 (95% CI: 0.44, 1.15) and so the system tends to over-predict the next day critical care inpatients by approximately 1 bed.Potential extensions to the basic model include adjustments for seasonality, case mix, probabilistic marginalisation and known discharges.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNothing to declare.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study did not require formal ethical approval. It has been reviewed by the LNWH NHS Trust R&D Office. Address: R&D, Level 7, Maternity Ward Northwick Park Hospital Watford Road Harrow HA1 3UJ Telephone: 0208 869 2688/5173/5829 E-Mail: Lnwh-tr.research@nhs.net All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes